Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

NORETHINDRONE AND E

Active
SPE2DP-27-T-0189Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2DP-27-T-0189 is a procurement request by the Defense Logistics Agency for Norethindrone and Ethinyl Estradiol Tablets, USP, identified by NSN 6505015062659. The requirement consists of multiple line items, including quantities of 3, 6, and 3 packages. Each package contains 168 tablets organized into six cycles of 28 tablets, with specific active ingredient dosages and inert tablets. The product is FDA regulated and must be stored at 25 degrees Celsius, with a non-extendable shelf life of 36 months. Delivery is required within five days after receipt of order, with FOB Destination terms, including a specific delivery location at Kadena Air Base in Okinawa, Japan. Compliance requires adherence to Medical Marking Standard No. 1 and MIL-STD-2073-1E for packaging and preservation. Items must be shipped in sealed unit containers within commercial exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract incorporates various federal and defense clauses, including the Buy American Act, safeguarding of covered defense information under DFARS 252.204-7012, and electronic invoicing via the Wide Area WorkFlow system. Offerors must be registered in the System for Award Management and comply with NAICS code 325412.

General Info

DLA procurement for Norethindrone and Ethinyl Estradiol tablets delivered to Kadena Air Base.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

1

RFQ SPE2DP-27-T-0189

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

3 updates
PhaseSolicitation
Posted

Solicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
NORETHINDRONE AND E
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
7 TABLETS WITH 0.5 MG & 35 MCG; 7 TABLETS WITH 0.75 MG & 35 MCG AND 7
TABLETS WITH 1 MG AND 25 MCG OF ACTIVE INGREDIENT PLUS 7 INERT TABLETS
28 TABLETS PER CYCLE, 6 CYCLES PER PKG UNIT OF ISSUE "PACKAGE" (6
CYCLES OF 28 TABLETS) SHALL HAVE A SHELF LIFE OF 36 MONTHS. NOT LESS
THAN 31 MONTHS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO DATE OF
DELIVERY TO THE GOVERNMENT.. LABELING AND MARKING MUST IN ACCORDANCE
WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013. STORE AT
25°C (77°F); EXCURSIONS PERMITTED TO 15°#30°C (59°#86°F)
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
1 PG = 168 TT
1 PG = 168 TT
This device or drug is regulated by the FDA.
SPE2DP-27-T-0189
SECTION B
Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
. SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00555-9012-58
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016658215 0001 PG 3.000
NSN/MATERIAL:6505015062659
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-506-2659 Quantity: 3 PG Purchase Request: 7016658215QTY: 3 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
HYDROXYPROPYL METHYLCE
Solicitation # SPE2DP-27-T-0185
Solicitation SPE2DP-27-T-0185 is a Small Business Set-Aside request for the procurement of Ocucoat Viscoelastic 1ML, a 2% hydroxypropyl methylcellulose ophthalmic solution (NSN 6505016331037). This FDA-regulated medical device is designed for high-volume, small-incision cataract surgery and lens inserter lubrication. The requirement consists of 5 boxes, with a delivery timeline of 79 days after receipt of order and an original required delivery date of October 27, 2026. Delivery is FOB Destination, with the final destination located at the USA Med Mat Ctr EUR in Kaiserslautern, Germany. The contract mandates strict quality and shelf-life compliance, requiring a non-extendable shelf life of 24 months per RS016. Packaging must be commercial and sealed to prevent damage, adhering to MIL-STD-2073-1E and DLA packaging requirements. Marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment. The procurement is subject to various DFARS and FAR clauses, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
EMOLLIENT LOTION
Solicitation # SPE2DP-27-T-0188
Solicitation SPE2DP-27-T-0188 is a procurement for emollient lotion under NAICS code 325412, managed by the Defense Logistics Agency. The requirement consists of multiple line items, including 500 bottles for CLIN 0001 and 12 bottles for CLIN 0002, with an additional 250 bottles for CLIN 0003. The product must be a non-sterile, homogeneous oil-in-water or water-in-oil emulsion with a pH range between 5.0 and 8.1 and a viscosity of 10,000 to 20,000 CPS. Each unit consists of a 240 ML (8 FL OZ) bottle equipped with a dispenser cap. The lotion must contain water, a suitable oil, an emulsifier, and a preservative, and it must be stored at controlled room temperature. Delivery is required within 20 days after the order, with specific required delivery dates ranging from June 17, 2026, to July 20, 2026. Shipments are designated as FOB Destination to various locations, including the USS George Washington, USS Iwo Jima, and the USNS Mercy. Packaging must comply with MIL-STD-129 and Medical Marking Standard No. 1, with non-hazardous materials following ASTM D3951 and hazardous materials adhering to TQ requirement IP025 and FED-STD-313. Palletization must follow DLA requirement RP001. The contract incorporates various FAR and DFARS clauses, including the Buy American Act, Wide Area Workflow for electronic payments, and destination inspection requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 423450
New
DIBBS
SODIUM CHLORIDE INJECT
Solicitation # SPE2DP-27-T-0167
Solicitation SPE2DP-27-T-0167 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Sodium Chloride Injection. The required product consists of 10 ML preservative-free, latex-free dispensing syringes, packaged in trays of 30 syringes per unit of issue. This FDA-regulated drug is classified as a Type I Code M item with a non-extendable shelf life of 24 months. The solicitation includes multiple contract line items for delivery to various locations, including Fort Bliss, Texas, and Fort Bragg, North Carolina, with a required delivery period of 20 days and an original required delivery date of October 27, 2026. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires commercial packaging per ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. Palletization must comply with DLA packaging requirement RP001. Terms are FOB Destination, with inspection and acceptance also occurring at the destination. Offerors must submit quotes via the DIBBS system and are encouraged to provide quantity ranges. This acquisition is not a small business set-aside and falls under NAICS code 423450. Payment and invoicing are to be processed electronically through the Wide Area WorkFlow system.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS